2508 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2025
JOURNALNature communications
PREMIER AUTEURPerrichet A
TITRECancer cell-derived IL-1β reverses chemo-immunotherapy resistance in non-small cell lung cancer.
ANNÉE2025
JOURNALCytotherapy
PREMIER AUTEURAudoux K
TITREInfluence of oxygen conditioning on the production of secretome by human mesenchymal stromal cells in stirred bioreactors.
ANNÉE2025
JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
PREMIER AUTEURAntoni D
TITRERadiotherapy guidelines for gliomas: 2025 update.
ANNÉE2025
JOURNALMethods (San Diego, Calif.)
PREMIER AUTEUROussalah A
TITREA smoothing method for DNA methylome analysis to enhance epigenomic signature detection in epigenome-wide association studies.
ANNÉE2025
JOURNALACS nano
PREMIER AUTEURJung S
TITREA Modular Supramolecular Peptide Platform Reveals Atomic-Number-Dependent Mechanisms Driving Radioenhancement.
ANNÉE2025
JOURNALClinics and research in hepatology and gastroenterology
PREMIER AUTEURLuciani L
TITREClinical and economic outcomes of adding durvalumab to gemcitabine/cisplatin in advanced biliary tract cancers: A multicenter descriptive study.
ANNÉE2025
JOURNALClinical nuclear medicine
PREMIER AUTEURAit Talhiq H
TITREFunctional Evaluation of Irreversible Electroporation for a Pancreatic Nonfunctioning Neuroendocrine Tumor Using 68Ga-DOTATOC PET/CT.
ANNÉE2025
JOURNALJournal of medicinal chemistry
PREMIER AUTEURThibaudeau C
TITREInverse Correlation between Endoplasmic Reticulum Stress Intensity and Antitumor Immune Response with Ruthenium(II)-Based Photosensitizers for the Photodynamic Therapy of Head and Neck Squamous Cell Carcinoma.
ANNÉE2025
JOURNALEuropean journal of nuclear medicine and molecular imaging
PREMIER AUTEURAit Talhiq H
TITRENormal organ [Ga]DOTATOC uptake during PRRT: challenging the assumption of stable background shaped by cold somatostatin analogues treatment.
ANNÉE2025
JOURNALCancer metastasis reviews
PREMIER AUTEURGolfier C
TITRECombining radiotherapy and immune checkpoint inhibitors in metastatic cancers: a 25-year review of safety outcomes by the ENRSO Group.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques